Quarterly Report • Nov 30, 2022
Quarterly Report
Open in ViewerOpens in native device viewer
Washington, D.C. 20549
November 30, 2022
Commission File Number 001-36761
1 Temasek Avenue #37-02B Millenia Tower Singapore 039192 (Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K on paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K on paper as permitted by Regulation S-T Rule 101(b)(7): ☐
EXHIBITS 99.1 AND 99.2 TO THIS REPORT ON FORM 6-K ARE INCORPORATED BY REFERENCE IN THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-201716) OF KENON HOLDINGS LTD. AND IN THE PROSPECTUSES RELATING TO SUCH REGISTRATION STATEMENT.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
KENON HOLDINGS LTD.
Date: November 30, 2022 By: /s/ Robert L. Rosen
Name: Robert L. Rosen Title: Chief Executive Officer
Exhibit 99.1

Singapore, November 30, 2022. Kenon Holdings Ltd. (NYSE: KEN, TASE: KEN) ("Kenon") announces its results for Q3 2022 and additional updates.
OPC
1 Represents 100% of ZIM's results. Kenon's share of ZIM's results for the three months ended September 30, 2022 was 21% (26% for three months ended September 30, 2021). 2 Adjusted EBITDA is a non-IFRS measure. See Exhibit 99.2 of Kenon's Form 6-K dated November 30, 2022 for the definition of ZIM's Adjusted EBITDA and OPC's and CPV's Adjusted EBITDA and a reconciliation to their respective net profit for the applicable period.
Kenon's consolidated results of operations from its operating companies essentially comprise the consolidated results of OPC Energy Ltd. ("OPC"). Our share of the results of ZIM Integrated Shipping Ltd. ("ZIM") are reflected under results from associated companies.
See Exhibit 99.2 of Kenon's Form 6-K dated November 30, 2022 for a summary of Kenon's consolidated financial information; a summary of OPC's consolidated financial information; a reconciliation of OPC's Adjusted EBITDA (which is a non-IFRS measure) to net profit (loss); summary of financial information of OPC's subsidiaries; and a reconciliation of ZIM's Adjusted EBITDA (which is a non-IFRS measure) to net profit.
The following discussion of OPC's results of operations is derived from OPC's consolidated financial statements, as translated into US dollars.
| OPC | ||||||
|---|---|---|---|---|---|---|
| Israel | U.S. | Total | Israel | U.S. | Total | |
| Q3 2022 | Q3 2021 | |||||
| \$ millions | ||||||
| Revenue | 147 | 16 | 163 | 116 | 17 | 133 |
| Cost of sales (excluding depreciation and | ||||||
| amortization) | 107 | 9 | 116 | 75 | 6 | 81 |
| Finance (expenses)/income, net | (9) | 1 | (8) | (86) | (2) | (88) |
| Share in profit of associated companies, net | - | 37 | 37 | - | 23 | 23 |
| Profit/(loss) for the period | 9 | 24 | 33 | (48) | 15 | (33) |
| Attributable to: | ||||||
| Equity holders of OPC | 9 | 14 | 23 | (38) | 10 | (28) |
| Non-controlling interest | - | 10 | 10 | (10) | 5 | (5) |
| Adjusted EBITDA | 34 | (6) | 28 | 36 | 2 | 38 |
| Proportionate share of Adjusted EBITDA of | ||||||
| associated companies | - | 50 | 50 | - | 16 | 16 |
OPC's revenue increased by \$30 million in Q3 2022, as compared to Q3 2021. As OPC's revenue is denominated in NIS, translation of its revenue into US Dollars had a negative impact of \$3 million. Set forth below is a discussion of significant changes in revenue between Q3 2022 and Q3 2021.
OPC's revenue from the sale of electricity to private customers derives from electricity sold at the generation component tariffs, as published by the Israeli Electricity Authority ("EA"), with some discount. Accordingly, changes in the generation component tariffs generally affect the prices paid under Power Purchase Agreements by customers of OPC-Rotem and OPC-Hadera. The weighted-average generation component tariff effective February 1, 2022, as published by the EA, was NIS 0.2869 per KW hour, which was approximately 13.6% higher than the weightedaverage generation component tariff in 2021 of NIS 0.2526 per KW hour. In April 2022, due to a reduction in excise tax on use of coal and to combat the high cost of living, the EA published a new weighted average generation component tariff effective May 1, 2022 of NIS 0.2764 per KW hour. On August 1, 2022, the electricity tariff was updated to NIS 0.314 per KW hour for the remainder of 2022, being an increase of 13.6% over the tariff published in May 2022.
OPC's cost of sales (excluding depreciation and amortization) increased by \$35 million in Q3 2022, as compared to Q3 2021. As OPC's cost of sales is denominated in NIS, translation of its cost of sales into US Dollars had a positive impact of \$2 million. Set forth below is a discussion of significant changes in cost of sales between Q3 2022 and Q3 2021.
• Natural gas and diesel oil consumption – Excluding the impact of exchange rate fluctuations, such cost of sales increased by \$11 million primarily as a result of (i) a \$6 million increase due to an increase in the generation component and foreign exchange rate movements and (ii) a \$5 million increase due to the receipt of compensation in respect of a delay in the commercial operation of Energean in Q3 2021.
Finance expenses, net decreased by \$80 million in Q3 2022, as compared to Q3 2021 primarily as a result of a non-recurring \$75 million expense due to the early repayment of the OPC-Rotem's project financing debt in October 2021.
OPC's share of profit of associated companies, net, consisting of share of results of five of the six operating plants in which CPV3 has interests, increased by \$14 million in Q3 2022, as compared to Q3 2021, primarily as a result of higher gas and electricity prices. This, together with improved plant efficiency, contributed to an increase in energy margins which was partially offset by the realization of hedging losses.
As at September 30, 2022, OPC's proportionate share of debt (including accrued interest) of CPV associated companies was \$878 million and proportionate share of cash and cash equivalents was \$14 million.
For further details of the performance of associated companies of CPV, refer to OPC's immediate report published on the Tel Aviv Stock Exchange on November 24, 2022 and the convenience English translations furnished by Kenon on Form 6-K on November 25, 2022. OPC's immediate report, and any information referenced therein, is not incorporated by reference herein.
As of September 30, 2022, OPC had cash and cash equivalents and deposits of \$342 million, restricted cash (used for debt service reserves) of \$14 million, and total consolidated indebtedness of \$1,021 million, consisting of \$38 million of short-term indebtedness and \$983 million of long-term indebtedness. As of September 30, 2022, a substantial portion of OPC's debt was denominated in NIS.
As previously reported, in July 2022, OPC issued 9,443,800 ordinary shares of NIS0.01 par value per share to the public. Gross issuance proceeds amounted to NIS 331 million (approximately \$94 million). Kenon took part in the issuance and was issued 3,898,000 ordinary shares for a gross amount of NIS 136 million (approximately \$39 million).
In September 2022, OPC issued 12,500,000 ordinary shares of NIS 0.01 par value per share to qualified investors. Gross issuance proceeds amounted to NIS 500 million (approximately \$141 million).
As a result of the public offering and private placement discussed above, Kenon holds approximately 54.7% of the outstanding shares of OPC.
3 CPV means collectively, CPV Power Holdings LP, Competitive Power Ventures Inc., CPV Renewable Energy Company Inc. and CPV Group LP, an entity in which OPC indirectly holds a 70% interest.

In November 2022, ZIM announced a third quarter 2022 dividend of approximately \$354 million, or \$2.95 per ordinary share, to be paid in December 2022. Kenon expects to receive \$73 million (\$70 million net of tax). ZIM also announced its revised full-year 2022 guidance.
For the quarter ended September 30, 2022, ZIM's revenue increased by 3% in Q3 2022 to \$3.2 billion, as compared to \$3.1 billion in Q3 2021.
ZIM's net profit was \$1.2 billion, as compared to \$1.5 billion in Q3 2021. ZIM's Adjusted EBITDA in Q3 2022 was \$1.9 billion, as compared to \$2.1 billion in Q3 2021.
ZIM carried 842 thousand TEUs in Q3 2022 representing a 5% decrease as compared to Q3 2021, in which ZIM carried 884 thousand TEUs. The average freight rate in Q3 2022 was \$3,353 per TEU, as compared to \$3,226 per TEU in Q3 2021.
For information on our agreement to sell our remaining interest in Qoros, and on Qoros' loan agreements and our pledges and guarantees and the ongoing proceedings, see Kenon's quarterly report on Form 6-K dated August 31, 2022 and most recent annual report on Form 20-F filed with the SEC.
As of September 30, 2022, Kenon's unconsolidated cash position was \$565 million. Kenon expects to receive additional cash of \$70 million in December 2022 following payment of ZIM's Q3 2022 dividend.
Kenon's unconsolidated cash position includes cash and cash equivalents, and fixed income and other treasury management instruments.
Kenon is a holding company that operates dynamic, primarily growth-oriented businesses. The companies it owns, in whole or in part, are at various stages of development:
For further information on Kenon's businesses and strategy, see Kenon's publicly available filings, which can be found on the SEC's website at www.sec.gov. Please also see http://www.kenonholdings.com for additional information.

4 Kenon has agreed to sell its remaining 12% interest to the Majority Shareholder.
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements. You can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "likely to" or other similar expressions. These statements include statements relating to ZIM's revised full-year 2022 guidance and the third quarter 2022 dividend declared by ZIM, and other non-historical matters. These statements are based on current expectations or beliefs and are subject to uncertainty and changes in circumstances. These forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond Kenon's control, which could cause the actual results to differ materially from those indicated in such forward-looking statements. Such risks include risks relating to payment of the dividend declared by ZIM, and future dividend payments and results and those risks set forth under the heading "Risk Factors" in Kenon's most recent Annual Report on Form 20-F filed with the SEC and other filings. The foregoing factors that could cause our actual results to differ materially from those contemplated in any forward-looking statement included in this press release should not be construed as exhaustive. Any forward-looking statements that we make in this press release speak only as of the date of such statements and we caution readers of this press release not to place undue reliance on these forward-looking statements. Except as required by law, Kenon undertakes no obligation to update these forward-looking statements, whether as a result of new information, future events, or otherwise.
Contact Info
Kenon Holdings Ltd. Mark Hasson Chief Financial Officer [email protected] Tel: +65 9726 8628
Appendix A: Summary of Kenon's consolidated financial information
Appendix E: Definition of ZIM's Adjusted EBITDA and non-IFRS reconciliation
Summary Kenon consolidated financial information
| September 30, | December 31, | ||
|---|---|---|---|
| 2022 | 2021 | ||
| \$ millions | |||
| Current assets | |||
| Cash and cash equivalents | 550 | 475 | |
| Short-term deposits and restricted cash | 10 | - | |
| Trade receivables | 52 | 63 | |
| Short-term derivative instruments | 4 | 1 | |
| Other investments | 358 | - | |
| Other current assets | 60 | 43 | |
| Total current assets | 1,034 | 582 | |
| Non-current assets | |||
| Investment in ZIM (associated company) | 1,341 | 1,354 | |
| Investment in OPC's associated companies | 625 | 545 | |
| Long-term restricted cash | 15 | 21 | |
| Long-term derivative instruments | 17 | 12 | |
| Long-term prepaid expenses and other non-current assets | 58 | 57 | |
| Deferred taxes | 6 | 19* | |
| Property, plant and equipment, net | 1,152 | 1,126 | |
| Intangible assets, net | 222 | 225 | |
| Right-of-use assets, net | 91 | 98 | |
| Total non-current assets | 3,527 | 3,457 | |
| Total assets | 4,561 | 4,039 | |
| Current liabilities | |||
| Current maturities of loans from banks and others | 54 | 38 | |
| Trade and other payables | 122 | 171 | |
| Short-term derivative instruments | 1 | 9 | |
| Current tax liabilities | 1 | - | |
| Deferred taxes | 4 | 21 | |
| Distribution payable | - | 189 | |
| Current maturities of lease liabilities | 17 | 19 | |
| Total current liabilities | 199 | 447 | |
| Non-current liabilities | |||
| Long-term loans from banks and others | 593 | 597 | |
| Debentures | 508 | 575 | |
| Deferred taxes | 95 | 95* | |
| Other non-current liabilities | 35 | 29 | |
| Long-term lease liabilities | 21 | 15 | |
| Total non-current liabilities | 1,252 | 1,311 | |
| Total liabilities | 1,451 | 1,758 | |
| Equity | |||
| Share capital | 50 | 602 | |
| Translation reserve | (1) | 26 | |
| Capital reserve | 39 | 26 | |
| Accumulated profit | 2,345 | 1,140 | |
| Equity attributable to owners of the Company Non-controlling interests |
2,433 677 |
1,794 487 |
|
| Total equity | 3,110 | 2,281 | |
| Total liabilities and equity | 4,561 | 4,039 |
*Reclassified
| For the nine months ended September 30, |
For the three months ended September 30, |
|||
|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | |
| \$ millions | \$ millions | |||
| Revenue | 429 | 353 | 163 | 133 |
| Cost of sales and services (excluding depreciation and amortization) | (313) | (239) | (116) | (81) |
| Depreciation and amortization | (39) | (40) | (14) | (14) |
| Gross profit | 77 | 74 | 33 | 38 |
| Selling, general and administrative expenses | (67) | (52) | (23) | (15) |
| Other income/(expenses) | 4 | (1) | 4 | - |
| Operating profit | 14 | 21 | 14 | 23 |
| Financing expenses | (39) | (130) | (12) | (92) |
| Financing income | 38 | 6 | 7 | 2 |
| Financing expenses, net | (1) | (124) | (5) | (90) |
| Loss related to Qoros | - | (251) | - | (196) |
| Gains related to ZIM | 202 | 12 | - | 2 |
| Share in profit of associated companies, net | ||||
| - ZIM |
947 | 818 | 241 | 400 |
| OPC's associated companies - |
57 | 7 | 37 | 23 |
| Profit before income taxes | 1,219 | 483 | 287 | 162 |
| Income tax (expense)/benefit | (34) | 18 | (16) | 8 |
| Profit for the period | 1,185 | 501 | 271 | 170 |
| Attributable to: | ||||
| Kenon's shareholders | 1,155 | 538 | 251 | 186 |
| Non-controlling interests | 30 | (37) | 20 | (16) |
| Profit for the period | 1,185 | 501 | 271 | 170 |
| Basic/diluted profit per share attributable to Kenon's shareholders (in dollars): | ||||
| Basic/diluted profit per share | 21.43 | 9.99 | 4.65 | 3.45 |
| For the nine months ended September 30, |
|||
|---|---|---|---|
| 2022 | 2021 | ||
| \$ millions | |||
| Cash flows from operating activities | |||
| Profit for the period | 1,185 | 501 | |
| Adjustments: | |||
| Depreciation and amortization | 44 | 43 | |
| Financing expenses, net | 1 | 124 | |
| Share in profit of associated companies, net | (1,004) | (825) | |
| Loss related to Qoros | - | 251 | |
| Gains related to ZIM | (202) | (12) | |
| Share-based payments | 9 | 3 | |
| Income tax expense/(benefit) | 34 | (18) | |
| 67 | 67 | ||
| Change in trade and other receivables | (11) | (10) | |
| Change in trade and other payables | 9 | (4) | |
| Change in employee benefits | - | 10 | |
| 65 | 63 | ||
| Dividends received from associated companies | 658 | 70 | |
| Net cash provided by operating activities | 723 | 133 |
| For the nine months | ||
|---|---|---|
| ended September 30, | ||
| 2022 | 2021 | |
| Cash flows from investing activities | \$ millions | |
| Short-term deposits and restricted cash, net | (10) | 542 |
| Short-term collaterals deposits, net | (15) | - |
| Investment in long-term deposits, net | 13 | 28 |
| Purchase of other investments | (672) | - |
| Proceeds from sale of other investments | 313 | - |
| Acquisition of subsidiary, less cash acquired | - | (655) |
| Investments in associated company, less cash acquired | (2) | (8) |
| Acquisition of property, plant and equipment | (216) | (151) |
| Acquisition of intangible assets | (9) | (1) |
| Reimbursement in respect of right-of-use asset | - | 5 |
| Proceeds from distribution of associated companies | 4 | 47 |
| Proceeds from sale of interest in ZIM | 464 | 64 |
| Long-term loans to an associate | - | (5) |
| Long-term advance deposits and prepaid expenses | (5) | (7) |
| Interest received | 2 | - |
| Payment of transactions in derivatives, net | - | (3) |
| Net cash used in investing activities | (133) | (144) |
| Cash flows from financing activities | ||
| Repayment of long-term loans, debentures and lease liabilities | (35) | (176) |
| Investments from holders of non-controlling interests in equity of subsidiary | 23 | 174 |
| Proceeds from issuance of share capital by a subsidiary to non-controlling interests, net of issuance expenses | 193 | 111 |
| Proceeds from issuance of debentures, net of issuance expenses | - | 263 |
| Receipt of long-term loans | 87 | 238 |
| Costs paid in advance in respect of taking out of loans | (2) | (4) |
| Payment in respect of derivative financial instruments, net | (2) | (15) |
| Dividends paid to holders of non-controlling interests | - | (10) |
| Cash distribution and dividends paid | (741) | (100) |
| Interest paid | (21) | (30) |
| Net cash (used in)/provided by financing activities | (498) | 451 |
| Increase in cash and cash equivalents | 92 | 440 |
| Cash and cash equivalents at beginning of the year | 475 | 286 |
| Effect of exchange rate fluctuations on balances of cash and cash equivalents | (17) | (3) |
| Cash and cash equivalents at end of the period | 550 | 723 |
Information regarding activities of the reportable segments are set forth in the following table.
| For the nine months ended September 30, 2022 | |||||
|---|---|---|---|---|---|
| OPC Israel | CPV Group | ZIM \$ millions |
Other | Consolidated Results |
|
| Revenue | 386 | 43 | - | - | 429 |
| Depreciation and amortization | (35) | (9) | - | - | (44) |
| Financing income | 8 | 25 | - | 5 | 38 |
| Financing expenses | (33) | (6) | - | - | (39) |
| Gains related to ZIM | - | - | 202 | - | 202 |
| Share in profit of associated companies | - | 57 | 947 | - | 1,004 |
| Profit/(loss) before taxes | 18 | 54 | 1,149 | (2) | 1,219 |
| Income tax expense | (7) | (10) | - | (17) | (34) |
| Profit/(loss) for the period | 11 | 44 | 1,149 | (19) | 1,185 |
| For the nine months ended September 30, 2021 | ||||||
|---|---|---|---|---|---|---|
| OPC Israel | CPV Group | ZIM \$ millions |
Other | Consolidated Results |
||
| Revenue | 315 | 38 | - | - | 353 | |
| Depreciation and amortization | (35) | (8) | - | - | (43) | |
| Financing income | 3 | 3 | - | - | 6 | |
| Financing expenses | (109) | (20) | - | (1) | (130) | |
| Loss related to Qoros | - | - | - | (251) | (251) | |
| Gains related to ZIM | - | - | 12 | - | 12 | |
| Share in profit of associated companies | - | 7 | 818 | - | 825 | |
| (Loss)/profit before taxes | (64) | (25) | 830 | (258) | 483 | |
| Income tax benefit/(expense) | 12 | 10 | - | (4) | 18 | |
| (Loss)/profit for the period | (52) | (15) | 830 | (262) | 501 | |
| 6 |
For the three months ended September 30, 2022
| Consolidated | |||||
|---|---|---|---|---|---|
| OPC Israel | CPV Group | ZIM | Other | Results | |
| \$ millions | |||||
| Revenue | 147 | 16 | - | - | 163 |
| Depreciation and amortization | (12) | (3) | - | - | (15) |
| Financing income | 1 | 3 | - | 3 | 7 |
| Financing expenses | (10) | (2) | - | - | (12) |
| Share in profit of associated companies | - | 37 | 241 | - | 278 |
| Profit before taxes | 13 | 29 | 241 | 4 | 287 |
| Income tax expense | (4) | (5) | - | (7) | (16) |
| Profit/(loss) for the period | 9 | 24 | 241 | (3) | 271 |
| For the three months ended September 30, 2021 | |||||
|---|---|---|---|---|---|
| OPC Israel | CPV Group | ZIM | Other | Consolidated Results |
|
| \$ millions | |||||
| Revenue | 116 | 17 | - | - | 133 |
| Depreciation and amortization | (12) | (2) | - | - | (14) |
| Financing income | - | 2 | - | - | 2 |
| Financing expenses | (86) | (4) | - | (2) | (92) |
| Loss related to Qoros | - | - | - | (196) | (196) |
| Gains related to ZIM | - | - | 2 | - | 2 |
| Share in (losses)/profits of associated companies | - | 23 | 400 | - | 423 |
| (Loss)/profit before taxes | (61) | 20 | 402 | (199) | 162 |
| Income tax benefit/(expense) | 13 | (5) | - | - | 8 |
| (Loss)/profit for the period | (48) | 15 | 402 | (199) | 170 |
| 7 |
| For the nine months ended September 30, |
For the three months ended September 30, |
|||
|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | |
| \$ millions | \$ millions | |||
| Revenue | 429 | 353 | 163 | 133 |
| Cost of sales (excluding depreciation and amortization) | (313) | (239) | (116) | (81) |
| Depreciation and amortization | (39) | (40) | (14) | (14) |
| Gross profit | 77 | 74 | 33 | 38 |
| Selling, general and administrative expenses | (57) | (46) | (21) | (11) |
| Other income | 1 | (1) | 1 | (3) |
| Operating profit | 21 | 15 | 13 | 24 |
| Financing expenses | (39) | (129) | (12) | (90) |
| Financing income | 33 | 6 | 4 | 2 |
| Financing expenses, net | (6) | (123) | (8) | (88) |
| Share of profit of associated companies, net | 57 | 7 | 37 | 23 |
| Profit before income taxes | 72 | (89) | 42 | (41) |
| Income taxes (expense)/benefit | (17) | 22 | (9) | 8 |
| Profit/(loss) for the period | 55 | (67) | 33 | (33) |
| Attributable to: | ||||
| Equity holders of the company | 44 | (52) | 24 | (28) |
| Non-controlling interest | 11 | (15) | 9 | (5) |
| Profit/(loss) for the period | 55 | (67) | 33 | (33) |
| For the nine months ended September 30, |
For the three months ended September 30, |
|||
|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | |
| \$ millions | \$ millions | |||
| Cash flows provided by operating activities | 82 | 88 | 58 | 37 |
| Cash flows used in investing activities | (239) | (126) | (80) | (25) |
| Cash flows provided by financing activities | 282 | 94 | 222 | (14) |
| Increase in cash and cash equivalents | 125 | 56 | 200 | 26 |
| Cash and cash equivalents at end of the period | 342 | 172 | 342 | 172 |
Summary Data from OPC's Consolidated Statement of Financial Position (Unaudited)
| As at | |||
|---|---|---|---|
| September 30, 2022 |
December 31, 2021 |
||
| \$ millions | |||
| Total financial liabilities1 | 1,021 | 1,076 | |
| Total monetary assets2 | 356 | 248 | |
| Investment in associated companies | 625 | 545 | |
| Total equity attributable to the owners | 989 | 730 | |
| Total assets | 2,687 | 2,458* |
Including loans from banks and financial institutions and debentures
Including cash and cash equivalents and deposits and restricted cash (used for debt service reserves)
*Reclassified
This press release, including the financial tables, presents OPC's Adjusted EBITDA and share of Adjusted EBITDA of its associated companies, which are non-IFRS financial measures.
OPC defines Adjusted EBITDA for each period as net profit before depreciation and amortization, financing expenses, net, income tax expense (benefit), changes in fair value of derivative financial instruments, items not in the ordinary course of business and/or having a non-recurring nature and proportionate share of losses of associated companies, net. Adjusted EBITDA is not recognized under IFRS or any other generally accepted accounting principles as a measure of financial performance and should not be considered as a substitute for net profit or loss, cash flow from operations or other measures of operating performance determined in accordance with IFRS. Adjusted EBITDA is not intended to represent funds available for dividends or other discretionary uses because those funds may be required for debt service, capital expenditures, working capital and other commitments and contingencies. There are limitations that impair the use of Adjusted EBITDA as a measure of OPC's profitability since it does not take into consideration certain costs and expenses that result from OPC's business that could have a significant effect on net profit, such as financial expenses, taxes, and depreciation and amortization.
OPC believes that the disclosure of Adjusted EBITDA and share of Adjusted EBITDA of its associated companies provide transparent and useful information to investors and financial analysts in their review of the company's, or its subsidiaries', or its associated companies' operating performance and in the comparison of such operating performance to the operating performance of other companies in the same industry or in other industries that have different capital structures, debt levels and/or income tax rates.
Set forth below are reconciliations of OPC's net profit to Adjusted EBITDA and share of net profit to share of Adjusted EBITDA of its associated companies for the periods presented. Other companies may calculate Adjusted EBITDA differently, and therefore this presentation of Adjusted EBITDA may not be comparable to other similarly titled measures used by other companies.
| For the three months ended September 30, |
||
|---|---|---|
| 2022 | 2021 | |
| \$ millions | ||
| Profit/(loss) for the period | 33 | (33) |
| Depreciation and amortization | 15 | 14 |
| Financing expenses, net | 8 | 88 |
| Share in profit of associated companies, net | (37) | (23) |
| Income tax expense/(benefit) | 9 | (8) |
| Adjusted EBITDA | 28 | 38 |
| Proportionate share of Adjusted EBITDA of associated companies | 50 | 16 |
| For the three months ended September 30, |
||
|---|---|---|
| 2022 | 2021 | |
| \$ millions | ||
| Share in profit of associated companies, net | 37 | 23 |
| Share of depreciation and amortization | 11 | 11 |
| Share of changes in fair value of derivative financial instruments | (4) | (13) |
| Share of financing expenses/(income), net | 6 | (5) |
| Proportionate share of Adjusted EBITDA of associated companies | 50 | 16 |
The tables below set forth debt, cash and cash equivalents, and debt service reserves for OPC's subsidiaries as of September 30, 2022 and December 31, 2021 (in \$ millions):
| As at September 30, 2022 | OPC Energy | OPC-Rotem | OPC-Hadera | OPC-Tzomet | CPV Keenan | Others | Total |
|---|---|---|---|---|---|---|---|
| Debt (including accrued | |||||||
| interest) | 518 | - | 191 | 222 | 90 | - | 1,021 |
| Cash and cash equivalents | |||||||
| and deposits | 236 | 11 | 9 | 7 | 1 | 78 | 342 |
| Restricted cash (used for debt | |||||||
| service reserves) | - | - | 14 | - | - | - | 14 |
| Net debt* | 282 | (11) | 168 | 215 | 89 | (78) | 665 |
| As at December 31, 2021 | OPC Energy | OPC-Rotem | OPC-Hadera | OPC-Tzomet | CPV Keenan | Others | Total |
| Debt (including accrued | 587 | - | 219 | 170 | 98 | 2 | 1,076 |
| interest) Cash and cash equivalents |
|||||||
| and deposits | 86 | 17 | 7 | 24 | 1 | 99 | 234 |
| Restricted cash (including | |||||||
| debt service reserves) | - | - | 14 | - | - | - | 14 |
*Net debt is defined as debt minus cash and cash equivalents and deposits and restricted cash.
This press release, including the financial tables, presents ZIM's Adjusted EBITDA, which is a non-IFRS financial measure.
ZIM defines Adjusted EBITDA as for each period as net profit before depreciation and amortization, financing expenses, net, income tax expense, impairment of assets, non-cash charter hire expenses, capital gains/losses beyond the ordinary course of business and expenses related to legal contingencies. Adjusted EBITDA is not recognized under IFRS or any other generally accepted accounting principles as a measure of financial performance and should not be considered as a substitute for net profit or loss, cash flow from operations or other measures of operating performance determined in accordance with IFRS. Adjusted EBITDA is not intended to represent funds available for dividends or other discretionary uses because those funds may be required for debt service, capital expenditures, working capital and other commitments and contingencies. There are limitations that impair the use of Adjusted EBITDA as a measure of ZIM's profitability since it does not take into consideration certain costs and expenses that result from ZIM's business that could have a significant effect on net profit, such as financial expenses, taxes, and depreciation and amortization.
ZIM believes that the disclosure of Adjusted EBITDA enables the comparison of operating performance between periods on a consistent basis. This measure should not be considered in isolation, or as a substitute for operating income, any other performance measure, or cash flow data, which were prepared in accordance with IFRS as measures of profitability or liquidity. In addition, non-IFRS financial measures may not be comparable to similarly titled measures reported by other companies, due to differences in the way these measures are calculated.
Set forth below is a reconciliation of ZIM's net profit to Adjusted EBITDA for the periods presented.
| For the three months ended September 30, |
|||
|---|---|---|---|
| 2022 | 2021 | ||
| \$ millions | |||
| Profit for the period | 1,166 | 1,463 | |
| Depreciation and amortization | 380 | 221 | |
| Financing expenses, net | 30 | 38 | |
| Income tax expense | 348 | 358 | |
| EBITDA | 1,924 | 2,080 | |
| Expenses related to legal contingencies | 10 | - | |
| Adjusted EBITDA | 1,934 | 2,080 | |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.